MARAGANORE JOHN Insider Trading Activity

Average Profitability
66.95%
Insider Buys Quantity
15
Insider Buys Sum
$3.29M
Insider Sells Quantity
48
Insider Sells Sum
$213.88M

Insider Activity of MARAGANORE JOHN

According to the SEC Form 4 filings, MARAGANORE JOHN, being in a position of

  1. director at Rapport Therapeutics, Inc. Common Stock,
    оver the last 12 months, has bought 9411 share for $248,891, and sold 0 shares,
    over all time since 2026-10-22, has bought 9411 share for $248,891, and sold 0 shares.

Biography of MARAGANORE JOHN

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $248,8911100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2026-10-22PurchaseRapport Therapeutics, Inc. Common Stock
RAPP
director
9,411
0.0196%
$26.45$248,891-4.9%
2021-11-12SaleAlnylam Pharmaceuticals, Inc.
ALNY
Chief Executive Officer
33,978
0.0288%
$171.52$5.83M-4.89%
2021-08-13SaleAlnylam Pharmaceuticals, Inc.
ALNY
Chief Executive Officer
33,979
0.029%
$199.78$6.79M-17.4%
2021-05-13SaleAlnylam Pharmaceuticals, Inc.
ALNY
Chief Executive Officer
33,979
0.0284%
$130.78$4.44M+28.15%
2021-02-25SaleAlnylam Pharmaceuticals, Inc.
ALNY
Chief Executive Officer
33,979
0.0292%
$147.31$5.01M+16.2%
2020-11-19SaleAlnylam Pharmaceuticals, Inc.
ALNY
Chief Executive Officer
34,765
0.0303%
$124.23$4.32M+32.94%
2020-08-20SaleAlnylam Pharmaceuticals, Inc.
ALNY
Chief Executive Officer
34,765
0.0299%
$136.13$4.73M+3.58%
2020-05-20SaleAlnylam Pharmaceuticals, Inc.
ALNY
Chief Executive Officer
34,765
0.0302%
$143.22$4.98M-3.49%
2020-02-20SaleAlnylam Pharmaceuticals, Inc.
ALNY
Chief Executive Officer
34,765
0.0305%
$131.85$4.58M+2.46%
2019-10-14SaleAlnylam Pharmaceuticals, Inc.
ALNY
Chief Executive Officer
49,456
0.0444%
$79.45$3.93M+61.38%
2019-05-15SaleAlnylam Pharmaceuticals, Inc.
ALNY
Chief Executive Officer
98,914
0.0578%
$43.22$4.27M+35.23%
2018-09-12SaleAgios Pharmaceuticals, Inc.
AGIO
director
0
–
$0$0-27.13%
2018-09-11SaleAgios Pharmaceuticals, Inc.
AGIO
director
13,555
0.0234%
$72.75$986,129-25.41%
2018-07-25SaleAlnylam Pharmaceuticals, Inc.
ALNY
Chief Executive Officer
100,000
0.0989%
$105.39$10.54M-22.81%
2017-11-22SaleAlnylam Pharmaceuticals, Inc.
ALNY
Chief Executive Officer
146,830
0.1511%
$130.90$19.22M-23.19%
2017-11-15SaleAlnylam Pharmaceuticals, Inc.
ALNY
Chief Executive Officer
148,000
0.1551%
$126.86$18.78M-18.64%
2016-07-20SaleAlnylam Pharmaceuticals, Inc.
ALNY
CEO
30,150
0.0351%
$65.58$1.98M-21.11%
2016-07-19SaleAlnylam Pharmaceuticals, Inc.
ALNY
CEO
30,152
0.0351%
$63.81$1.92M-19.01%
2016-04-20SaleAlnylam Pharmaceuticals, Inc.
ALNY
Chief Executive Officer
30,150
0.0354%
$67.51$2.04M-22.16%
2016-04-19SaleAlnylam Pharmaceuticals, Inc.
ALNY
Chief Executive Officer
30,152
0.0356%
$67.41$2.03M-21.54%
Total: 58
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.